639 related articles for article (PubMed ID: 11720816)
21. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
[TBL] [Abstract][Full Text] [Related]
22. Two modes of homologous C3 deposition on Ramos Burkitt's lymphoma cell substrains co-expressing DAF (CD55), CD59, and CR2 (CD21), and on cells lacking them.
Seya T; Hara T; Okada M; Kojima A; Matsumoto M; Akedo H
Int Immunol; 1992 Dec; 4(12):1361-71. PubMed ID: 1283697
[TBL] [Abstract][Full Text] [Related]
23. Protection of xenogeneic cardiac endothelium from human complement by expression of CD59 or DAF in transgenic mice.
Byrne GW; McCurry KR; Kagan D; Quinn C; Martin MJ; Platt JL; Logan JS
Transplantation; 1995 Nov; 60(10):1149-56. PubMed ID: 7482724
[TBL] [Abstract][Full Text] [Related]
24. Protection of human breast cancer cells from complement-mediated lysis by expression of heterologous CD59.
Yu J; Caragine T; Chen S; Morgan BP; Frey AB; Tomlinson S
Clin Exp Immunol; 1999 Jan; 115(1):13-8. PubMed ID: 9933415
[TBL] [Abstract][Full Text] [Related]
25. Rat T cells express neither CD55 nor CD59 and are dependent on Crry for protection from homologous complement.
Hanna S; Spiller O; Linton SM; Mead RJ; Morgan B
Eur J Immunol; 2002 Feb; 32(2):502-9. PubMed ID: 11828367
[TBL] [Abstract][Full Text] [Related]
26. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.
Moutabarrik A; Nakanishi I; Namiki M; Hara T; Matsumoto M; Ishibashi M; Okuyama A; Zaid D; Seya T
Lymphokine Cytokine Res; 1993 Jun; 12(3):167-72. PubMed ID: 7688580
[TBL] [Abstract][Full Text] [Related]
27. Expression of complement regulatory proteins CR1, DAF, MCP and CD59 in haematological malignancies.
Guc D; Canpinar H; Kucukaksu C; Kansu E
Eur J Haematol; 2000 Jan; 64(1):3-9. PubMed ID: 10680700
[TBL] [Abstract][Full Text] [Related]
28. bFGF and VEGF synergistically enhance endothelial cytoprotection via decay-accelerating factor induction.
Mason JC; Lidington EA; Ahmad SR; Haskard DO
Am J Physiol Cell Physiol; 2002 Mar; 282(3):C578-87. PubMed ID: 11832343
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of CD59 up-regulation induced in porcine endothelial cells by alphaGal ligation and its association with protection from complement.
Grubbs BC; Benson BA; Dalmasso AP
Xenotransplantation; 2003 Sep; 10(5):387-97. PubMed ID: 12950982
[TBL] [Abstract][Full Text] [Related]
30. Complement regulatory proteins on the sperm surface: relevance to sperm motility.
Jiang H; Pillai S
Am J Reprod Immunol; 1998 Apr; 39(4):243-8. PubMed ID: 9553648
[TBL] [Abstract][Full Text] [Related]
31. Cell surface regulators of complement, 5I2 antigen, and CD59, in the rat eye and adnexal tissues.
Bardenstein DS; Cheyer C; Okada N; Morgan BP; Medof ME
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):519-24. PubMed ID: 9950613
[TBL] [Abstract][Full Text] [Related]
32. Test for ability of decay-accelerating factor (DAF, CD55) and CD59 to alleviate complement-mediated damage of xeno-erythrocytes.
Miyagawa S; Shirakura R; Matsumiya G; Nakata S; Matsuda H; Hatanaka M; Matsumoto M; Kitamura H; Seya T
Scand J Immunol; 1993 Jul; 38(1):37-44. PubMed ID: 7687071
[TBL] [Abstract][Full Text] [Related]
33. Induction of decay-accelerating factor by cytokines or the membrane-attack complex protects vascular endothelial cells against complement deposition.
Mason JC; Yarwood H; Sugars K; Morgan BP; Davies KA; Haskard DO
Blood; 1999 Sep; 94(5):1673-82. PubMed ID: 10477692
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of human complement-dependent cell lysis by bovine aortic endothelial cells transfected with membrane-bound complement-regulatory factor (DAF and HRF20) gene using a retroviral vector.
Hayashi S; Isobe K; Emi N; Yokoyama I; Okada H; Nakashima I; Takagi H
Eur Surg Res; 1996; 28(6):440-6. PubMed ID: 8954321
[TBL] [Abstract][Full Text] [Related]
35. Adenovirus-mediated triple gene transfer of human complement regulating proteins to the porcine endothelial cell.
Nagahama M; Shiraishi M; Oshiro T; Muto Y
Transplant Proc; 2000 Nov; 32(7):2511-3. PubMed ID: 11120272
[No Abstract] [Full Text] [Related]
36. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells.
Nagahama M; Shiraishi M; Oshiro T; Taira K; Sugawa H; Nozato E; Nomura H; Nagamine M; Muto Y
Transpl Int; 2002 May; 15(5):205-11. PubMed ID: 12012040
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of DAF (CD55) on orbital fibroblasts by cytokines. Differential effects of TNF-beta and TNF-alpha.
Cocuzzi ET; Bardenstein DS; Stavitsky A; Sundarraj N; Medof ME
Curr Eye Res; 2001 Aug; 23(2):86-92. PubMed ID: 11840345
[TBL] [Abstract][Full Text] [Related]
38. Molecular remodelling of human CD46 for xenotransplantation: designing a potent complement regulator without measles virus receptor activity.
Begum NA; Murakami Y; Mikata S; Matsumoto M; Hatanaka M; Nagasawa S; Kinoshita T; Seya T
Immunology; 2000 May; 100(1):131-9. PubMed ID: 10809968
[TBL] [Abstract][Full Text] [Related]
39. Relative contributions of decay accelerating factor (DAF), membrane cofactor protein (MCP) and CD59 in the protection of melanocytes from homologous complement.
Venneker GT; Vodegel RM; Okada N; Westerhof W; Bos JD; Asghar SS
Immunobiology; 1998 Feb; 198(4):476-84. PubMed ID: 9562871
[TBL] [Abstract][Full Text] [Related]
40. Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases.
Miwa T; Song WC
Int Immunopharmacol; 2001 Mar; 1(3):445-59. PubMed ID: 11367529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
